The Interplay of Cannabinoids: What Is Established About THC, CBD and Co.

What this is about

The cannabis plant contains more than 100 different cannabinoids – among them THC, CBD, CBG, CBN and CBC. For a long time they were looked at in isolation; today the question is whether and how they influence one another when taken together. This assumed interaction is often summed up under the term entourage effect.

This article deals specifically with the interplay of cannabinoids with one another – above all THC and CBD. The broader question of what terpenes contribute is covered in the article on the entourage effect. One point first: that combinations act differently from single compounds is plausible and partly documented – but the mechanism behind it is not always a synergy in the strict sense.

The main cannabinoids at a glance

Factual, without promises of effect:

  • THC (tetrahydrocannabinol) – the main psychoactive constituent, directly activates the CB1 and CB2 receptors.
  • CBD (cannabidiol) – not intoxicating; binds only weakly to CB1/CB2 and acts mainly through other routes.
  • CBG (cannabigerol) – the chemical precursor from which THC and CBD form during growth.
  • CBN (cannabinol) – forms through the breakdown/ageing of THC, weakly psychoactive.
  • CBC (cannabichromene) – not intoxicating; studied mainly in preclinical work.

THC and CBD: what the combination does

The best-studied pair is THC–CBD. A widespread assumption is that CBD “dampens” THC. The evidence is less consistent than this rule of thumb suggests:

  • Observational data – for example from epilepsy treatment – suggest that CBD-rich plant extracts can work at lower doses and with fewer side effects than isolated CBD (Pamplona et al., 2018). Such data are not randomised, however, and are therefore prone to bias.
  • Controlled studies do not show a uniform picture: one RCT found no significant change in the effect of THC across different CBD:THC ratios (Englund et al., 2023).
  • Another RCT found that high-dose CBD did not weaken the effect of THC but strengthened it – and did so pharmacokinetically: CBD inhibits liver enzymes (CYP), slows the breakdown of THC and so raises its blood level (Gorbenko et al., 2024).

This is the decisive point: an observed combination effect can be a genuine synergy at the receptor – or simply be due to one compound changing the breakdown of another. From the outside both look similar, but pharmacologically they are different (Christensen et al., 2023).

The other cannabinoids

For combinations such as CBG with CBD, or the calming effect attributed to CBN, there are hypotheses and individual, mostly preclinical findings (cell culture, animal models). Solid clinical evidence for specific cannabinoid–cannabinoid synergies beyond THC–CBD is so far scarce. These attributions therefore belong in the category of research leads, not established effects.

“Full-spectrum works better” – not established as a blanket claim

From this interplay it is often concluded that whole flowers or full-spectrum extracts are fundamentally superior to isolates. As a general statement this is not proven: systematic reviews find no solid evidence for a consistent synergy, and “full-spectrum” is moreover a term without a standardised definition (Christensen et al., 2023; review 2024). For individual cases – most likely THC–CBD – there are indications; no general law can be derived from them.

Assessment

  • Established: THC and CBD influence each other; the effect depends strongly on dose and ratio.
  • Important: combination effects are often pharmacokinetic (altered breakdown) rather than receptor synergy.
  • Unfinished: cannabinoid combinations beyond THC–CBD are mostly preclinical.
  • Not established: the blanket superiority of full-spectrum over isolate.

Readers interested in the contribution of terpenes and the whole discussion will find the details in the article on the entourage effect; the individual cannabinoids are described in the corresponding overview.

This article describes the state of research and is not medical advice. The effects mentioned come from partly preclinical or non-randomised studies and are no assurance of any effect. It gives no strain or product recommendations.

Sources